cvot tirzepatide In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. Full SURPASS-CVOT trial results: https://nej.md/4qd5rLx Post hoc analysis of SURPASS-CVOT

Vasoactive Intestinal Peptide (VIP), another gut-derived peptide, acts as a potent vasodilator and has positive inotropic effects on the heart

The dosing schedule was strategically designed to be given in the critical period of balloon placement, specifically during the second to fourth months and after balloon removal in the seventh and eighth months

Furthermore, microfluidics offers outstanding opportunities for the nanodrug delivery systems production processes as it enhances controllability and uniformity (Zhang et al., 2023)

By conjugating toxins for excretion, L-glutathione supports phase II detoxification and neutralizes ROS, preventing oxidative damage to lipids, proteins, and DNA

10.1523/JNEUROSCI.5045-04.2005 [DOI] [PMC free article] [PubMed] [Google Scholar] Haberstock-Debic H., Wein M., Barrot M., Colago E